NUVL - Nuvalent dips on offering of $200M Class A common stock
- Nuvalent ( NASDAQ: NUVL ) shares fell over 6% Monday morning after the biopharmaceutical company launched an underwritten public offering of $200M of its shares of Class A common stock.
- All shares are being offered by Nuvalent ( NUVL ).
- In addition, Nuvalent ( NUVL ) expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of Class A common stock sold in the public offering at the public offering price less underwriting discounts and commissions.
- Terms of the offering are yet to be determined.
For further details see:
Nuvalent dips on offering of $200M Class A common stock